Intriguingly, the ITGB4 status of the TCs and the E-/P-selectin status of the tumor stroma also affected the local immune environment in these immunocompetent hosts: under both conditions per se, the number of CD3+ cells specifically increased at the tumor margin, but not in the tumor center (Fig. 9D). This evidence concerns the gene ITGB4 and neoplasm.